Borregaard Past Earnings Performance
Past criteria checks 2/6
Borregaard has been growing earnings at an average annual rate of 17.5%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 9.2% per year. Borregaard's return on equity is 15.5%, and it has net margins of 10.9%.
Key information
17.5%
Earnings growth rate
17.5%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 9.2% |
| Return on equity | 15.5% |
| Net Margin | 10.9% |
| Next Earnings Update | 29 Jan 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Borregaard makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 7,478 | 813 | 1,359 | 0 |
| 30 Jun 24 | 7,243 | 800 | 1,359 | 0 |
| 31 Mar 24 | 7,257 | 839 | 1,359 | 0 |
| 31 Dec 23 | 7,132 | 870 | 1,359 | 0 |
| 30 Sep 23 | 7,297 | 935 | 1,204 | 0 |
| 30 Jun 23 | 7,335 | 937 | 1,204 | 0 |
| 31 Mar 23 | 7,116 | 906 | 1,204 | 0 |
| 31 Dec 22 | 6,881 | 892 | 1,204 | 0 |
| 30 Sep 22 | 6,557 | 810 | 1,158 | 0 |
| 30 Jun 22 | 6,234 | 782 | 1,158 | 0 |
| 31 Mar 22 | 6,001 | 763 | 1,158 | 0 |
| 31 Dec 21 | 5,805 | 692 | 1,158 | 0 |
| 30 Sep 21 | 5,697 | 711 | 1,142 | 0 |
| 30 Jun 21 | 5,528 | 612 | 1,142 | 0 |
| 31 Mar 21 | 5,375 | 480 | 1,142 | 0 |
| 31 Dec 20 | 5,328 | 436 | 1,142 | 0 |
| 30 Sep 20 | 5,224 | 353 | 1,098 | 0 |
| 30 Jun 20 | 5,203 | 372 | 1,098 | 0 |
| 31 Mar 20 | 5,185 | 393 | 1,098 | 0 |
| 31 Dec 19 | 5,063 | 417 | 1,098 | 0 |
| 30 Sep 19 | 5,048 | 459 | 1,083 | 0 |
| 30 Jun 19 | 4,959 | 455 | 1,083 | 0 |
| 31 Mar 19 | 4,818 | 465 | 1,083 | 0 |
| 31 Dec 18 | 4,785 | 476 | 1,083 | 0 |
| 30 Sep 18 | 4,703 | 486 | 1,025 | 0 |
| 30 Jun 18 | 4,642 | 506 | 1,025 | 0 |
| 31 Mar 18 | 4,699 | 555 | 1,025 | 0 |
| 31 Dec 17 | 4,618 | 566 | 1,025 | 0 |
| 30 Sep 17 | 4,591 | 599 | 955 | 0 |
| 30 Jun 17 | 4,604 | 609 | 955 | 0 |
| 31 Mar 17 | 4,515 | 582 | 955 | 0 |
| 31 Dec 16 | 4,492 | 555 | 955 | 0 |
| 30 Sep 16 | 4,416 | 540 | 887 | 0 |
| 30 Jun 16 | 4,383 | 495 | 887 | 0 |
| 31 Mar 16 | 4,270 | 433 | 887 | 0 |
| 31 Dec 15 | 4,164 | 386 | 887 | 0 |
| 30 Sep 15 | 4,081 | 346 | 813 | 0 |
| 30 Jun 15 | 4,015 | 344 | 813 | 0 |
| 31 Mar 15 | 3,954 | 343 | 813 | 0 |
| 31 Dec 14 | 3,939 | 334 | 813 | 0 |
| 30 Sep 14 | 3,956 | 328 | 782 | 0 |
| 30 Jun 14 | 3,969 | 338 | 782 | 0 |
| 31 Mar 14 | 3,928 | 335 | 782 | 0 |
| 31 Dec 13 | 3,886 | 335 | 782 | 0 |
Quality Earnings: BO4 has high quality earnings.
Growing Profit Margin: BO4's current net profit margins (10.9%) are lower than last year (12.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BO4's earnings have grown by 17.5% per year over the past 5 years.
Accelerating Growth: BO4's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BO4 had negative earnings growth (-13%) over the past year, making it difficult to compare to the Chemicals industry average (5%).
Return on Equity
High ROE: BO4's Return on Equity (15.5%) is considered low.